KeyBanc Raises Price Target on American Healthcare REIT to $58
On May 28, 2026, KeyBanc Capital raised its price target for American Healthcare REIT (AHR) from $55 to $58 and maintained an Overweight rating. The firm cited strong performance in RIDEA segments, a stronger balance sheet following recent equity issuance, and increased NFFO estimates for 2026 and 2027.
Tickers: $AHR